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Further Evidence that Exclusive 
Breast-Feeding Reduces Mother-to-Child HIV 
Transmission Compared With Mixed Feeding
Mary Glenn Fowler 
T
he critical role of breast-
feeding in improving infant 
and under-ﬁve-year survival in 
resource-limited settings has been well 
documented since the mid-1970s. A 
pooled analysis by the World Health 
Organization (WHO) of a number 
of studies on the impact of breast-
feeding on child survival showed that 
the protective effect is strongest in the 
ﬁrst six months of life, with a 4–6-fold 
survival beneﬁt for breast-fed infants 
[1]. The beneﬁt extends throughout 
the ﬁrst year of life, with a 1.4–1.8-
fold protective effect against mortality 
during months six through twelve [1]. 
Balancing the Beneﬁts and Risks of 
Breast-Feeding
With the emergence of the global HIV 
pandemic, prevention of mother-to-
child transmission became an early 
research focus. The risk of transmission 
of HIV through breast-feeding was 
documented by observational studies 
from both developed and developing 
countries [2,3]. After the ﬁrst one to 
two months of breast-feeding, where 
the risk of transmission is particularly 
high, several studies reported a 
continual sustained risk of infants 
becoming infected of between 0.6%–
0.9% per month [3,4] during later 
breast-feeding. Studies also reported a 
cumulative absolute risk of 12%–16% 
postnatal transmission due to breast 
milk exposure when breast-feeding is 
extended to 18–24 months [5,6]. 
In resource-limited settings, 
balancing the general beneﬁts of 
breast-feeding against the low but 
ongoing risk of HIV transmission has 
been a major dilemma for perinatal 
HIV researchers, policy makers, and 
most importantly, for HIV-infected 
women. In these settings, breast-
feeding is the cultural norm, and to 
not breast-feed may lead to disclosure 
of a woman’s HIV status. Given these 
realities, HIV-infected women have to 
make the difﬁcult choice as to whether 
to expose their baby to a potentially 
fatal viral infection or whether to place 
their infant at risk for early death due 
to malnutrition and other infectious 
diseases if they opt not to breast-feed.
Initial research efforts addressing 
breast milk transmission focused on 
epidemiologic studies to delineate risk 
factors for transmission during breast-
feeding. A number of these risk factors 
are now known and include increased 
maternal viral load and clinical disease 
status [7], mastitis and local breast 
disease [8,9], duration of breast-
feeding [3], and mixed feeding ( i.e., 
adding other foods and liquids to the 
infant’s diet in addition to breast milk) 
in the ﬁrst months of life [10–12]. 
Since the late 1990s, observational 
studies nested within trials also 
suggested a protective role for 
exclusive breast-feeding against HIV 
transmission. The initial study from 
South Africa [10] did not indicate a 
statistically signiﬁcant protective effect 
of early exclusive breast-feeding after 
controlling for maternal risk factors. 
Subsequently, however, several other 
studies have suggested a strong and 
statistically signiﬁcant protective effect 
of exclusive breast-feeding for the ﬁrst 
three to six months of life compared 
with mixed feeding in reducing the 
risk of postnatal transmission, an effect 
that was sustained and which translated 
into a long-term reduction in overall 
transmission [11,12]. But there were 
still several limitations in these studies 
in terms of sample size, the inability to 
fully control for maternal virologic and 
immunologic factors, and the difﬁculty 
in validating actual infant feeding 
practices, since most data on infant 
feeding were based on maternal self-
report.
The Zambia Exclusive 
Breastfeeding Study
The carefully executed, prospective 
Zambia Exclusive Breastfeeding 
Study (ZEBS) by Louise Kuhn and 
colleagues, published recently in 
PLoS ONE, was carried out in Lusaka, 
Zambia from 2001–2004 [13]. While 
the ZEBS data on infant feeding and 
transmission outcomes are based on 
observational data, the relatively large 
sample size and the prospective design 
helped to address a number of the 
limitations of the earlier studies. The 
ZEBS analyses aimed a priori to test 
the hypothesis that exclusive breast-
feeding was related to a reduction in 
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transmission during the ﬁrst months of 
life when compared with other types of 
infant feeding. The study also assessed 
the feasibility of intensive counseling to 
achieve high uptake of exclusive breast-
feeding throughout the ﬁrst four to 
six months of life. The ﬁndings add to 
and strengthen our understanding of 
the role of exclusive breast-feeding in 
protecting HIV-exposed infants against 
early postnatal HIV transmission.
The analyses used infant feeding 
and infant outcome data on 958 
infants born to HIV-infected women 
who were encouraged to exclusively 
breast-feed for four months. The data 
were gathered as part of a randomized 
clinical trial assessing infant HIV 
infection and HIV-free survival 
outcomes in the ﬁrst 24 months among 
infants born to HIV-infected mothers. 
In this trial, mothers were randomly 
assigned either to early cessation 
of exclusive breast-feeding by four 
months or to continued breast-feeding 
generally into the second year of life 
and gradual introduction of other 
foods. Serial maternal immunologic 
markers (CD4 and CD8 counts) were 
collected, together with hemoglobin 
and viral load. 
Infant feeding data included 
frequent gathering of detailed infant 
dietary history questionnaires and 
home observations. Infant real-time 
HIV testing by polymerase chain 
reaction was also done at frequent 
intervals, allowing close ascertainment 
of the timing of transmission. Statistical 
analyses were robust ( Kaplan-Meier 
time-to-event survival analyses as well 
as Cox proportional hazards models), 
which allowed the investigators to assess 
the independent role of early exclusive 
breast-feeding on transmission 
risk while also controlling for key 
independent variables known to be 
associated with mother-to-child HIV 
transmission. Age-speciﬁc hazard ratios 
were generated from months four to 24 
based on infant feeding patterns. 
The ZEBS ﬁndings on early infant 
feeding patterns and HIV outcomes 
are informative both for health 
programmers and researchers. First, 
the study shows that extremely high 
levels of exclusive breast-feeding 
(84%) in the ﬁrst four to six months 
of life can be achieved with effective 
counseling of mothers. Second, the 
study documents a substantial early 
protective role for exclusive breast-
feeding against early HIV transmission: 
there was a 3.5–4-fold increased hazard 
of infant infection by age four months 
among those infants who were not 
exclusively breast-fed compared with 
those who were. Third, the study 
found that the vast majority (86%) of 
early transmissions occurred among 
women who had lower CD4 counts. 
These ﬁndings would suggest that more 
liberal use of highly active antiretroviral 
therapy (HAART) among lactating 
women with CD4 counts less than 350 
cells/mm3 should substantially reduce 
early transmissions through breast milk. 
Implications of the New Study
There are a number of implications of 
these ﬁndings for clinical practitioners, 
researchers, and policy makers alike. 
1. Exclusive breast-feeding in the 
ﬁrst four to six months of life is feasible 
for most women and can be achieved 
by providing strong and consistent 
counseling messages.
 2. Given its early protective overall 
health beneﬁt, in addition to providing 
protection against HIV transmission 
compared to mixed feeding, exclusive 
breast-feeding should be strongly 
promoted by policy makers as part of 
baby-friendly maternal and child health 
services. Such promotion should be 
aimed both at HIV negative-women and 
those HIV-positive women in resource-
limited settings for whom alternatives 
to breast-feeding (e.g., use of formula 
feeding) are not safe, feasible, or 
culturally acceptable.
3. To achieve this goal, adequate 
resources must be allocated for training 
of maternal child health staff to provide 
counseling messages that promote 
exclusive breast-feeding throughout 
the ﬁrst six months of life. There needs 
to be sufﬁcient funding for adequate 
stafﬁng given the high volumes using 
such services.
4. More liberal treatment guidelines 
supporting sustained maternal HAART 
for women with CD4 counts under 350 
cells/mm3 throughout lactation could 
potentially both improve maternal 
health and also signiﬁcantly reduce 
the risk of transmission during breast-
feeding.
Next Steps
For programs aimed at preventing 
mother-to-child transmission of HIV, 
the encouraging data from the ZEBS 
on the protective role of exclusive 
breast-feeding reafﬁrm the need to 
promote exclusive breast-feeding 
for the majority of HIV-infected 
women in resource-limited settings 
throughout the ﬁrst six months. This 
recommendation is based on 2001 
guidance from WHO and UNICEF 
that exclusive breast-feeding should 
be supported in the ﬁrst months of 
life unless “AFASS” criteria are met 
for replacement feeding: i.e., unless 
replacement feeding is “acceptable, 
feasible, affordable, sustainable, and 
safe” [14]. Counseling on infant 
feeding for newly delivered HIV-
infected women should emphasize 
the importance of exclusive breast-
feeding for at least six months 
unless the AFASS criteria are met. 
Women should be reassessed at six 
months after delivery to see if they 
can safely cease breast-feeding or 
whether instead they should continue 
breast-feeding with introduction of 
complementary foods. WHO has 
recently come out with updated HIV 
and Infant Feeding Guidelines that 
consider the ZEBS data as well as other 
new ﬁndings [15]. 
For researchers, one key question is 
how to make breast-feeding safer for 
HIV-exposed infants while preserving 
the protective infant survival beneﬁts of 
breast-feeding. Several clinical trials are 
underway addressing the possible role 
of antiretrovirals used either for infant 
prophylaxis or given to HIV-infected 
women during pregnancy as well as 
postpartum during the ﬁrst six months 
of lactation. Future clinical trials 
being planned will assess extended 
prophylaxis throughout the entire 
breast-feeding period. Another area for 
research would be the development of 
an efﬁcacious prophylactic infant HIV 
vaccine that could allow HIV-exposed 
infants to receive the nutritional and 
immunologic beneﬁts of breast-feeding 
while effectively reducing their risk 
of acquiring HIV through prolonged 
breast-feeding.
Overall, these ﬁndings from the 
ZEBS study are reassuring, and 
reinforce the earlier results from 
Zimbabwe and South Africa on the 
protective effect of exclusive breast-
feeding not only on infant survival but 
also in reducing the risk of postnatal 
transmission.  
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